215 related articles for article (PubMed ID: 25479907)
1. Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents.
Zhao Y; Zhou P; Liu B; Bambakidis T; Mazitschek R; Alam HB; Li Y
J Surg Res; 2015 Apr; 194(2):544-550. PubMed ID: 25479907
[TBL] [Abstract][Full Text] [Related]
2. Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.
Finkelstein RA; Li Y; Liu B; Shuja F; Fukudome E; Velmahos GC; deMoya M; Alam HB
J Surg Res; 2010 Sep; 163(1):146-54. PubMed ID: 20599223
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
Li Y; Liu B; Zhao H; Sailhamer EA; Fukudome EY; Zhang X; Kheirbek T; Finkelstein RA; Velmahos GC; deMoya M; Hales CA; Alam HB
Shock; 2009 Nov; 32(5):517-23. PubMed ID: 19295477
[TBL] [Abstract][Full Text] [Related]
4. Surviving lethal septic shock without fluid resuscitation in a rodent model.
Li Y; Liu B; Fukudome EY; Kochanek AR; Finkelstein RA; Chong W; Jin G; Lu J; deMoya MA; Velmahos GC; Alam HB
Surgery; 2010 Aug; 148(2):246-54. PubMed ID: 20561658
[TBL] [Abstract][Full Text] [Related]
5. Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock.
Li Y; Liu B; Fukudome EY; Lu J; Chong W; Jin G; Liu Z; Velmahos GC; Demoya M; King DR; Alam HB
Surgery; 2011 Sep; 150(3):442-51. PubMed ID: 21878229
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.
Chong W; Li Y; Liu B; Zhao T; Fukudome EY; Liu Z; Smith WM; Velmahos GC; deMoya MA; Alam HB
J Surg Res; 2012 Dec; 178(2):851-9. PubMed ID: 22868051
[TBL] [Abstract][Full Text] [Related]
7. Citrullinated histone H3: a novel target for the treatment of sepsis.
Li Y; Liu Z; Liu B; Zhao T; Chong W; Wang Y; Alam HB
Surgery; 2014 Aug; 156(2):229-34. PubMed ID: 24957671
[TBL] [Abstract][Full Text] [Related]
8. Novel pharmacologic treatment attenuates septic shock and improves long-term survival.
Zhao T; Li Y; Liu B; Liu Z; Chong W; Duan X; Deperalta DK; Velmahos GC; Alam HB
Surgery; 2013 Aug; 154(2):206-13. PubMed ID: 23889949
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
You BR; Park WH
Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
[TBL] [Abstract][Full Text] [Related]
10. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
11. Creating a "pro-survival" phenotype through epigenetic modulation.
Li Y; Liu B; Gu X; Kochanek AR; Fukudome EY; Liu Z; Zhao T; Chong W; Zhao Y; Zhang D; Libermann TA; Alam HB
Surgery; 2012 Sep; 152(3):455-64. PubMed ID: 22938904
[TBL] [Abstract][Full Text] [Related]
12. Vorinostat protects against calcium oxalate-induced kidney injury in mice.
Wang L; Chen W; Peng Z; Liu C; Zhang C; Guo Z
Mol Med Rep; 2015 Sep; 12(3):4291-4297. PubMed ID: 26095064
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
Qiu X; Rong X; Yang J; Lu Y
BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
[TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.
Zhao T; Li Y; Liu B; Wu E; Sillesen M; Velmahos GC; Halaweish I; Alam HB
Surgery; 2014 Aug; 156(2):214-20. PubMed ID: 24957668
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.
Tan J; Zhuang L; Jiang X; Yang KK; Karuturi KM; Yu Q
J Biol Chem; 2006 Apr; 281(15):10508-15. PubMed ID: 16476732
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells.
Jeon HS; Ahn MY; Park JH; Kim TH; Chun P; Kim WH; Kim J; Moon HR; Jung JH; Kim HS
Int J Oncol; 2010 Aug; 37(2):419-28. PubMed ID: 20596669
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes.
Shi ZJ; Ouyang DY; Zhu JS; Xu LH; He XH
Int Immunopharmacol; 2012 Apr; 12(4):580-7. PubMed ID: 22369900
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells.
Chou PJ; Sarwar MS; Wang L; Wu R; Li S; Hudlikar RR; Wang Y; Su X; Kong AN
Cancer Prev Res (Phila); 2023 Jun; 16(6):321-332. PubMed ID: 36867722
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study.
Chong W; Li Y; Liu B; Liu Z; Zhao T; Wonsey DR; Chen C; Velmahos GC; deMoya MA; King DR; Kung AL; Alam HB
J Trauma Acute Care Surg; 2012 Feb; 72(2):347-53; discussion 353-4. PubMed ID: 22327976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
